Results 221 to 226 of about 32,260 (226)
Some of the next articles are maybe not open access.

Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro

Journal of Cellular Biochemistry, 2018
Osteoclasts are highly differentiated terminal cells formed by fusion of hematopoietic stem cells. Previously, osteoprotegerin (OPG) inhibit osteoclast differentiation and bone resorption by blocking receptor activator of nuclear factor‐κB ligand (RANKL)
Xishuai Tong   +9 more
semanticscholar   +1 more source

Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients.

Current Vascular Pharmacology, 2019
BACKGROUND Osteoprotegerin and osteopontin have recently emerged as key factors in both vascular remodelling and atherosclerosis progression. Interleukin-6 (IL-6) is an inflammatory cytokine with a key role in atherosclerosis.
K. Maniatis   +9 more
semanticscholar   +1 more source

The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics

Calcified Tissue International, 2019
L. Rochette   +6 more
semanticscholar   +1 more source

An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases

World Journal of Pediatrics, 2018
G. Brunetti   +7 more
semanticscholar   +1 more source

Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.

VASA. Zeitschrift fur Gefasskrankheiten, 2018
K. Demková   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy